Ok, so we’ve come to accept that digital media is going to play a dominant role in the future of pharma marketing activities (now being dubbed pharma3.0). As I mentioned in my last post there are some trailblazers who are championing the use of highly interactive channels such as the iphone or Nintendo wii. Now the worry is that pharma execs will note the potential gains of pursuing marketing activities through digital and social media but that it will just remain a pipe dream. The fear of becoming entrenched in a complex web of legislation and or (in extreme circumstances) punishment in the form of civil and criminal sanctions is just too difficult to stomach. (more…)
